[Herceptin monotherapy in HER2(+) recurrent breast carcinoma].
View on PubMed
Abstract & Figures
Sorry, we couldn't extract an abstract for this paper.
Figures and Tables
Sorry, we couldn't extract any figures or tables for this paper.
Sorry, we couldn't extract any citations for this paper.
Sorry, we couldn't extract any references for this paper.
Loading similar papers…
Slides referencing similar topics
The HER/ERBB Family Targeting the HER Family members and related pathways HER2 as a target in Gastric Cancer TRASTUZUMAB (Herceptin®) APPROVED Immune mechanism of action thru HER2 Trastuzumab Clinical Trials in Gastric cancer
Hilda Wong + 3 • Nov 02, 2017
Breasts and Mammary Glands Breasts and Mammary Glands
Sep 06, 2017
Serous Carcinoma Implants of Serous Ovarian Carcinoma Serous Ovarian Neoplasms*
Richard W. Lieberman • Oct 17, 2017